Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine and Gemcitabine in Platinum-Resistant Ovarian Cancer
NCT01196559Phase 2Completed
- Sponsor
- The Catholic University of Korea
- Start
- Jan 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, gemcitabine in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by The Catholic University of Korea. Started Jan 2011; status: completed.
02
Drugs
vinorelbinegemcitabine
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01196559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196559.